Lee J J, Parsons M E
Biosciences Department, University of Hertfordshire, Hatfield, Hertfordshire, United Kingdom.
J Pharmacol Exp Ther. 2000 Nov;295(2):607-13.
The mechanisms coupled to adenosine A(1)- and histamine H(3)-receptors have been examined in the presynaptic inhibition of acetylcholine (ACh) release from the guinea pig ileum. Electrically evoked twitch contractions were used as a measure of neuronal ACh release. A(1)- and H(3)-receptors were activated by adenosine and R-(alpha)-methylhistamine (RAMH), respectively. The neuroinhibitory effect of adenosine and RAMH was augmented in the presence of the N-type Ca(2+) channel blocker, omega-conotoxin GVIA but unaffected by the L-type Ca(2+) channel blocker, nifedipine. The irreversible adenylyl cyclase inhibitor, MDL-12330A, potentiated the action of both adenosine and RAMH. Conversely, neither agonist was affected by the cAMP phosphodiesterase III and IV inhibitors, SKF-95654 and Ro-20-1724, respectively, or the cAMP antagonist, (R(p))-adenosine 3',5'-cyclic monophosphorothioate triethylamine. The neuromodulatory effect of adenosine, only, was potentiated by the cGMP phosphodiesterase V inhibitors, SKF-96231 and 1,3-dimethyl-6-(2-propoxy-5-methanesulfonylamidophenyl)- pyrazolo[3, 4-d]pyrimidin-4-(5H)-one but was unmodified by the cGMP analog, 8-bromo-cGMP or the guanylyl cyclase inhibitors, N-methylhydroxylamine and 1H-[1,2,4]oxadiazolo[4, 3-a]quinoxaline-1-one (ODQ). N-Methylhydroxylamine reduced, and ODQ potentiated, the inhibitory action of H(3)-receptor activation, but 8-bromo-cGMP was without effect. The study suggests that presynaptic A(1)- and H(3)-receptors inhibit cholinergic neurotransmission in the guinea pig ileum by limiting the availability of intraneuronal Ca(2+) via inhibition of N-type Ca(2+) channels. The balance of evidence does not support the involvement of the adenylyl cyclase/cAMP or guanylyl cyclase/cGMP systems.
在豚鼠回肠中,对与腺苷A(1)受体和组胺H(3)受体相关的机制进行了研究,以探讨其对乙酰胆碱(ACh)释放的突触前抑制作用。电诱发的抽搐收缩被用作神经元ACh释放的指标。腺苷和R-(α)-甲基组胺(RAMH)分别激活A(1)受体和H(3)受体。在存在N型钙通道阻滞剂ω-芋螺毒素GVIA的情况下,腺苷和RAMH的神经抑制作用增强,但不受L型钙通道阻滞剂硝苯地平的影响。不可逆的腺苷酸环化酶抑制剂MDL-12330A增强了腺苷和RAMH的作用。相反,两种激动剂分别不受环磷酸腺苷磷酸二酯酶III和IV抑制剂SKF-95654和Ro-20-1724或环磷酸腺苷拮抗剂(R(p))-腺苷3',5'-环磷酸硫代三乙胺的影响。仅腺苷的神经调节作用被环磷酸鸟苷磷酸二酯酶V抑制剂SKF-96231和1,3-二甲基-6-(2-丙氧基-5-甲磺酰胺基苯基)-吡唑并[3,4-d]嘧啶-4-(5H)-酮增强,但不受环磷酸鸟苷类似物8-溴环磷酸鸟苷或鸟苷酸环化酶抑制剂N-甲基羟胺和1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮(ODQ)的影响。N-甲基羟胺降低了H(3)受体激活的抑制作用,而ODQ增强了该作用,但8-溴环磷酸鸟苷没有影响。该研究表明,突触前A(1)受体和H(3)受体通过抑制N型钙通道来限制神经元内钙离子的可用性,从而抑制豚鼠回肠中的胆碱能神经传递。现有证据不支持腺苷酸环化酶/环磷酸腺苷或鸟苷酸环化酶/环磷酸鸟苷系统参与其中。